Sightera Biosciences

Sightera Biosciences, located in Incubator Darwin, is a spin-off project of the University of Antwerp in collaboration with Antwerp University Hospital. Sightera develops innovative small molecules within the field of oncology and regenerative medicine by combining patient-centered models with artificial intelligence. 

 
Sightera's goal is to significantly accelerate traditional drug development by incorporating an alternative and complementary technology to conventional small molecule discovery, namely SPAR technology. With our unique SPAR (Structure-Patient-Activity-Relationship) technology, we integrate chemical structures and patient-centered models to create more effective and relevant therapies at the start of the drug discovery process. Sightera aims to streamline traditional drug development by developing novel small molecules with high patient relevance within a short timeframe.